Skip to main content
Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

10 wyświetleń
Pobierz
Farmaceutyczny

Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.

Dawkowanie

Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Moc

Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Wielkość opakowania

Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Postać

Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Źródło

European Medicines Agency

Zobacz źródło

Profil bezpieczeństwa

Przeciwwskazania

Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Skutki uboczne

Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Powiązane artykuły kliniczne

Skanuj ten kod QR, aby szybko uzyskać dostęp do tej strony na swoim urządzeniu mobilnym.

QR Code